Is there a future for DNA-based molecular devices in diabetes management?

J Diabetes Sci Technol. 2007 May;1(3):440-4. doi: 10.1177/193229680700100319.

Abstract

We provide a thought experiment in advanced molecular engineering leading to the construction of a molecular robot acting as a DNA-based closed-loop device for the management of diabetes mellitus. The key components of this robot are nucleic acid enzymes regulated allosterically by glucose. In the presence of glucose above a threshold level the robot moves, releasing insulin from a lawn covered with insulin, but stops in its tracks whenever glucose decreases to a level below threshold; thus, the robot could provide an insulin release response to spikes in glucose concentration in real time.

Keywords: allosteric regulation; deoxyribozymes; glucose sensor; insulin release; molecular robots.